Low-dose nivolumab plus induction chemotherapy for locally advanced or unresectable head and neck cancer is associated with high response rates and conversion to definitive therapy

J Josh Thomas Georgy S Soumya Susan Regi R Rosh Varghese Georgy B Balu Krishna Sasidharan A Anjana Joel D Deepa Susan Joy Philip A Ajoy Oommen John D Divya Bala Thumaty P Praveen Kumar Marimuthu P Prashant Jambunathan K Kovilapu Harikrishna Z Zachariah Thomas N N. Jansi Rani A Amit Jiwan Tirkey M Meera Thomas R Rajesh Isiah A Ashish Singh

Article Details

Volume / Issue Vol. 15, Issue 1
Published October 08, 2025
ISSN 2045-2322
Publisher Nature Portfolio

Journal Info

Scientific Reports

Nature Portfolio

ISSN: 2045-2322 Open Access Life Sciences

Authors (17)

J

Josh Thomas Georgy

S

Soumya Susan Regi

R

Rosh Varghese Georgy

B

Balu Krishna Sasidharan

A

Anjana Joel

D

Deepa Susan Joy Philip

A

Ajoy Oommen John

D

Divya Bala Thumaty

P

Praveen Kumar Marimuthu

P

Prashant Jambunathan

K

Kovilapu Harikrishna

Z

Zachariah Thomas

N

N. Jansi Rani

A

Amit Jiwan Tirkey

M

Meera Thomas

R

Rajesh Isiah

A

Ashish Singh